Cargando…
Association of obesity and different metabolic status with prognosis in patients with bladder cancer: a retrospective cohort study
BACKGROUND AND OBJECTIVES: Patients with bladder cancer (BC) are at high risk for recurrence rates and readmission costs. However, the evidence about obesity and metabolic abnormalities on the BC prognosis was inconsistent. Our primary aim was to determine the impact of obesity and different metabol...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10685784/ https://www.ncbi.nlm.nih.gov/pubmed/38033708 http://dx.doi.org/10.1177/17562872231213720 |
_version_ | 1785151703540039680 |
---|---|
author | Dong, Yingchun Cheng, Yiping Guo, Honglin Sun, Jiaxing Han, Junming Zhong, Fang Li, Qihang Wang, Dawei Chen, Wenbin Fan, Xiude Zhao, Jiajun |
author_facet | Dong, Yingchun Cheng, Yiping Guo, Honglin Sun, Jiaxing Han, Junming Zhong, Fang Li, Qihang Wang, Dawei Chen, Wenbin Fan, Xiude Zhao, Jiajun |
author_sort | Dong, Yingchun |
collection | PubMed |
description | BACKGROUND AND OBJECTIVES: Patients with bladder cancer (BC) are at high risk for recurrence rates and readmission costs. However, the evidence about obesity and metabolic abnormalities on the BC prognosis was inconsistent. Our primary aim was to determine the impact of obesity and different metabolic status on the readmission risk in patients with BC. DESIGN AND METHODS: We identified 16,649 patients with BC using the 2018 Nationwide Readmissions Database who were hospitalized from January to June 2018 and followed for 180 days. The primary outcome was 180-day readmission. The multivariate Cox regression analysis and ordered logistic regression were performed to analyze data. RESULTS: Obesity and metabolic abnormalities were associated with an increased readmission risk in patients with BC [obesity: adjusted hazard ratio (aHR) = 1.08, 95% confidence interval (CI): 1.01–1.16; hyperglycemia: aHR = 1.11, 95% CI: 1.05–1.17; hypertension: aHR = 1.09, 95% CI: 1.03–1.15]. Compared with non-obese and no metabolic abnormalities, the risk of readmission was significantly increased in patients with metabolic abnormalities, irrespective of obesity (non-obese and metabolic abnormalities: aHR = 1.07, 95% CI: 1.02–1.13; obese and metabolic abnormalities: aHR = 1.20, 95% CI: 1.10–1.31), but not in obese and no metabolic abnormalities. These associations were consistent in patients aged 60 years or older and the surgery group. Moreover, hyperglycemia, hypertension, and a graded increment of metabolic risk were associated with an increased readmission risk. We also found increased length of stay for readmission in patients with obesity and metabolic abnormalities (aOR = 1.17, 95% CI: 1.00–1.36). CONCLUSION: Obesity with metabolic abnormalities and metabolic abnormalities alone were associated with higher readmission risks in patients with BC. It is suggested that prevention should focus not only on obesity but also on metabolic abnormalities to decrease the risk of readmission. |
format | Online Article Text |
id | pubmed-10685784 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-106857842023-11-30 Association of obesity and different metabolic status with prognosis in patients with bladder cancer: a retrospective cohort study Dong, Yingchun Cheng, Yiping Guo, Honglin Sun, Jiaxing Han, Junming Zhong, Fang Li, Qihang Wang, Dawei Chen, Wenbin Fan, Xiude Zhao, Jiajun Ther Adv Urol Original Research BACKGROUND AND OBJECTIVES: Patients with bladder cancer (BC) are at high risk for recurrence rates and readmission costs. However, the evidence about obesity and metabolic abnormalities on the BC prognosis was inconsistent. Our primary aim was to determine the impact of obesity and different metabolic status on the readmission risk in patients with BC. DESIGN AND METHODS: We identified 16,649 patients with BC using the 2018 Nationwide Readmissions Database who were hospitalized from January to June 2018 and followed for 180 days. The primary outcome was 180-day readmission. The multivariate Cox regression analysis and ordered logistic regression were performed to analyze data. RESULTS: Obesity and metabolic abnormalities were associated with an increased readmission risk in patients with BC [obesity: adjusted hazard ratio (aHR) = 1.08, 95% confidence interval (CI): 1.01–1.16; hyperglycemia: aHR = 1.11, 95% CI: 1.05–1.17; hypertension: aHR = 1.09, 95% CI: 1.03–1.15]. Compared with non-obese and no metabolic abnormalities, the risk of readmission was significantly increased in patients with metabolic abnormalities, irrespective of obesity (non-obese and metabolic abnormalities: aHR = 1.07, 95% CI: 1.02–1.13; obese and metabolic abnormalities: aHR = 1.20, 95% CI: 1.10–1.31), but not in obese and no metabolic abnormalities. These associations were consistent in patients aged 60 years or older and the surgery group. Moreover, hyperglycemia, hypertension, and a graded increment of metabolic risk were associated with an increased readmission risk. We also found increased length of stay for readmission in patients with obesity and metabolic abnormalities (aOR = 1.17, 95% CI: 1.00–1.36). CONCLUSION: Obesity with metabolic abnormalities and metabolic abnormalities alone were associated with higher readmission risks in patients with BC. It is suggested that prevention should focus not only on obesity but also on metabolic abnormalities to decrease the risk of readmission. SAGE Publications 2023-11-28 /pmc/articles/PMC10685784/ /pubmed/38033708 http://dx.doi.org/10.1177/17562872231213720 Text en © The Author(s), 2023 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Original Research Dong, Yingchun Cheng, Yiping Guo, Honglin Sun, Jiaxing Han, Junming Zhong, Fang Li, Qihang Wang, Dawei Chen, Wenbin Fan, Xiude Zhao, Jiajun Association of obesity and different metabolic status with prognosis in patients with bladder cancer: a retrospective cohort study |
title | Association of obesity and different metabolic status with prognosis in patients with bladder cancer: a retrospective cohort study |
title_full | Association of obesity and different metabolic status with prognosis in patients with bladder cancer: a retrospective cohort study |
title_fullStr | Association of obesity and different metabolic status with prognosis in patients with bladder cancer: a retrospective cohort study |
title_full_unstemmed | Association of obesity and different metabolic status with prognosis in patients with bladder cancer: a retrospective cohort study |
title_short | Association of obesity and different metabolic status with prognosis in patients with bladder cancer: a retrospective cohort study |
title_sort | association of obesity and different metabolic status with prognosis in patients with bladder cancer: a retrospective cohort study |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10685784/ https://www.ncbi.nlm.nih.gov/pubmed/38033708 http://dx.doi.org/10.1177/17562872231213720 |
work_keys_str_mv | AT dongyingchun associationofobesityanddifferentmetabolicstatuswithprognosisinpatientswithbladdercanceraretrospectivecohortstudy AT chengyiping associationofobesityanddifferentmetabolicstatuswithprognosisinpatientswithbladdercanceraretrospectivecohortstudy AT guohonglin associationofobesityanddifferentmetabolicstatuswithprognosisinpatientswithbladdercanceraretrospectivecohortstudy AT sunjiaxing associationofobesityanddifferentmetabolicstatuswithprognosisinpatientswithbladdercanceraretrospectivecohortstudy AT hanjunming associationofobesityanddifferentmetabolicstatuswithprognosisinpatientswithbladdercanceraretrospectivecohortstudy AT zhongfang associationofobesityanddifferentmetabolicstatuswithprognosisinpatientswithbladdercanceraretrospectivecohortstudy AT liqihang associationofobesityanddifferentmetabolicstatuswithprognosisinpatientswithbladdercanceraretrospectivecohortstudy AT wangdawei associationofobesityanddifferentmetabolicstatuswithprognosisinpatientswithbladdercanceraretrospectivecohortstudy AT chenwenbin associationofobesityanddifferentmetabolicstatuswithprognosisinpatientswithbladdercanceraretrospectivecohortstudy AT fanxiude associationofobesityanddifferentmetabolicstatuswithprognosisinpatientswithbladdercanceraretrospectivecohortstudy AT zhaojiajun associationofobesityanddifferentmetabolicstatuswithprognosisinpatientswithbladdercanceraretrospectivecohortstudy |